Utilize expertise in medicinal chemistry supported by AI and machine learning platforms, to design antiviral molecules with high potency, desirable pharmacokinetic and pharmacodynamic properties, and are suitable for overcoming drug resistance.

Develop drug formulations for treatment of seasonal or pandemic respiratory viral diseases. Retain flexibility in design, aiming to ensure that all affected persons are treated effectively including the elderly, immunocompromised and otherwise vulnerable populations.

Evaluate new medications using our extensive network of partners and experience with international routes for expediting first-in-man studies and for evaluating clinical impact in many regions of the world.

Distribute valuable antiviral medications through partnering with large pharmaceutical companies or direct distribution channels with established international networks.